Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Comparison Study of the Efficacy of Quetiapine and Haloperidol in Agitated Adults in Emergency Room
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007
by University of Southern California.
Recruitment status was Active, not recruiting
Study NCT00457366 Information provided by University of Southern California
First Received on April 4, 2007. Last Updated on March 24, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Agitation
Additional conditions recognized in this trial
Emergencies
Psychomotor Agitation
More general conditions related to this trial
Disease Attributes
Dyskinesias
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Pathologic Processes
Psychomotor Disorders
Signs and Symptoms
Interventions listed in this trial
Quetiapine
Additional drug interventions recognized in this trial
Benztropine
Haloperidol
Haloperidol decanoate
Lorazepam
More general drug interventions related to this trial
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antiemetics
Antiparkinson Agents
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Cholinergic Agents
Cholinergic Antagonists
Dopamine Agents
Dopamine Antagonists
Dopamine Uptake Inhibitors
GABA Agents
GABA Modulators
Gastrointestinal Agents
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
University of Southern California
AstraZeneca
Back to top of Main Content